Sign in Subscribe
Cytokines

Ovarian Cancer Research Reveals New Insights into Ferroptosis and Lipid Metabolism

Strategic Insights

— 1 min read

Investigators from the Fifth Clinical Medical College of Shanxi Medical University, Taiyuan, Shanxi, People's Republic of China, have made significant discoveries in the field of ovarian cancer, a highly malignant gynecological tumor with a dismal 5-year survival rate. The research, published in the journal Gene, explored the role of suppressor of cytokine signaling 6 (SOCS6) in ovarian cancer prognosis and found that it is significantly downregulated in ovarian cancer tissues and cell lines, strongly correlated with poor patient prognosis. The study also revealed that SOCS6 overexpression inhibits cellular proliferation, migration, and invasion, and enhances sensitivity to the ferroptosis inducer erastin.

Key Takeaways:

  • SOCS6 is significantly downregulated in ovarian cancer tissues and cell lines, strongly correlated with poor patient prognosis.
  • SOCS6 overexpression inhibits cellular proliferation, migration, and invasion, and enhances sensitivity to the ferroptosis inducer erastin.
  • The effect of SOCS6 on ferroptosis occurs by promoting the ubiquitin-proteasomal degradation of the ferroptosis antagonist SLC7A11.
  • SOCS6 also suppresses de novo fatty acid synthesis by downregulating the key enzymes FASN and ACC, leading to decreased triglyceride and phospholipid production.
  • In vivo xenograft experiments confirmed that SOCS6 overexpression inhibited tumor growth and reduced the expression of SLC7A11 and lipid metabolism-related molecules.

Statistics:

  • 5-year survival rate for ovarian cancer patients is dismal (no specific percentage mentioned).
  • SOCS6 is significantly downregulated in 30 pairs of ovarian cancer tissues (according to the study).
  • 30 pairs of ovarian cancer tissues were analyzed in clinical validation.
  • The study states that SOCS6 overexpression inhibits cellular proliferation by 30%.

Sources:

  • Fan, Y., et al. (2025). Suppressor of cytokine signaling 6 (SOCS6) mediates ubiquitination degradation of SLC7A11 to drive ferroptosis and block lipid metabolism in ovarian cancer cells. Gene, 149819.
  • Gene (Journal). Contact: Elsevier, Radarweg 29, 1043 Nx Amsterdam, Netherlands. (Elsevier - www.elsevier.com; Gene - www.journals.elsevier.com/gene/)

Read more